Skip to content
The U.S. bioscience industry generated $3.2 trillion in overall output in 2023, according to the latest report from the Biotechnology Innovation Organization (BIO) and the Council of State Bioscience […]
U.S. biotech generates $3.2 trillion in a year, report shows Read More »
Pictured, from left: Scott McMurray, Deputy Commissioner, Georgia Quick Start; Dave Penake, CEO, Saol Therapeutics; Margie Battle, Manager, Georgia BioScience Training Center; Megan Heaphy,
Rep. Hank Johnson and BIO tour biotech training facility in Atlanta Read More »
Virginia Gov. Glenn Youngkin on Sept. 17 received the 2024 Governor of the Year Award from the Biotechnology Innovation Organization (BIO) in recognition of
Virginia Gov. Youngkin named BIO’s Governor of the Year Read More »
In recent years, the number of disruptive, cutting-edge therapies approved or under review by the Food and Drug Administration (FDA) has grown substantially. So-called
Innovative payment arrangements bring transformative therapies from the lab to patients Read More »
Global oncology company BeiGene on July 23 announced the opening of its new flagship U.S. facility in Hopewell, NJ, at the Princeton West Innovation
BeiGene opens new flagship research-manufacturing facility in NJ Read More »
A guest post by Doug Edgeton, president and CEO of the North Carolina Biotechnology Center. We’re marking two big life sciences anniversaries this year
NCBiotech: 40 years of growing North Carolina life sciences Read More »
With the passage of the Inflation Reduction Act (IRA) and the growing number of prescription drug affordability boards (PDABs), patients and the biotech industry
BIO 2024: PDABs and IRA pose a murky threat to patient access Read More »
On April 10, Life Sciences PA awarded Biotechnology Innovation Organization (BIO) President & CEO John F. Crowley the Hubert J.P. Schoemaker Leadership Award. The
Life Sciences PA recognizes John F. Crowley for biotech leadership Read More »
With over 116,000 employees across 7,462 businesses, Texas has become a leader in biotechnology and life sciences, a recent report revealed. “The life science
New report highlights booming life sciences sector in Texas Read More »
The Colorado Prescription Drug Affordability Board (PDAB) has many patients, patient advocacy groups, and bioscience organizations in the state worried. As one of the
Colorado PDAB could limit patient access to medicines Read More »
